Cargando…
Evaluation of confirmatory data following the Article 12 MRL review for napropamide
The applicant UPL Europe Ltd submitted a request to the competent national authority in Slovenia to evaluate the confirmatory data that were identified for napropamide in the framework of the maximum residue levels (MRLs) review under Article 12 of Regulation (EC) No 396/2005 as not available. To ad...
Autores principales: | Bellisai, Giulia, Bernasconi, Giovanni, Carrasco Cabrera, Luis, Castellan, Irene, Del Aguila, Monica, Ferreira, Lucien, Giner Santonja, German, Greco, Luna, Jarrah, Samira, Leuschner, Renata, Perez, Javier Martinez, Miron, Ileana, Nave, Stefanie, Pedersen, Ragnor, Reich, Hermine, Ruocco, Silvia, Santos, Miguel, Scarlato, Alessia Pia, Theobald, Anne, Tiramani, Manuela, Verani, Alessia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358196/ https://www.ncbi.nlm.nih.gov/pubmed/37485252 http://dx.doi.org/10.2903/j.efsa.2023.8125 |
Ejemplares similares
-
Evaluation of confirmatory data following the Article 12 MRL review for fenbuconazole
por: Bellisai, Giulia, et al.
Publicado: (2023) -
Evaluation of confirmatory data following the Article 12 MRL review for S‐metolachlor
por: Bellisai, Giulia, et al.
Publicado: (2023) -
Evaluation of confirmatory data following the Article 12 MRL review for paclobutrazol
por: Bellisai, Giulia, et al.
Publicado: (2022) -
Evaluation of confirmatory data following the Article 12 MRL review for tebufenpyrad
por: Bellisai, Giulia, et al.
Publicado: (2023) -
Evaluation of confirmatory data following the Article 12 MRL review for thiabendazole
por: Bellisai, Giulia, et al.
Publicado: (2022)